You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,703,181

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,703,181 protect, and when does it expire?

Patent 8,703,181 protects ONIVYDE and is included in one NDA.

This patent has forty-seven patent family members in nineteen countries.

Summary for Patent: 8,703,181

Patent landscape, scope, and claims:

Title:	Liposomes useful for drug delivery
Abstract:	The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provides methods of making the liposome compositions provided by the present invention.
Inventor(s):	Hong; Keelung (San Francisco, CA), Drummond; Daryl C. (Pacifica, CA), Kirpotin; Dmitri (San Francisco, CA)
Assignee:	Merrimack Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:	13/654,373
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form; Delivery; Formulation;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 8,703,181

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ipsen	ONIVYDE	irinotecan hydrochloride	INJECTABLE, LIPOSOMAL;INTRAVENOUS	207793-001	Oct 22, 2015		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe				TREATMENT OF PANCREATIC CANCER	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,703,181

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1746976	⤷ Subscribe	300885	Netherlands	⤷ Subscribe
European Patent Office	1746976	⤷ Subscribe	122017000042	Germany	⤷ Subscribe
European Patent Office	1746976	⤷ Subscribe	CA 2017 00030	Denmark	⤷ Subscribe
European Patent Office	1746976	⤷ Subscribe	LUC00026	Luxembourg	⤷ Subscribe
European Patent Office	1746976	⤷ Subscribe	2017C/027	Belgium	⤷ Subscribe
European Patent Office	1746976	⤷ Subscribe	1790033-3	Sweden	⤷ Subscribe
European Patent Office	1746976	⤷ Subscribe	132017000076571	Italy	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.